Novel therapeutic strategies in pancreatic cancer: moving beyond cytotoxic chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel therapeutic strategies in pancreatic cancer: moving beyond cytotoxic chemotherapy

Published:2023-10-19 Issue:12 Volume:23 Page:1237-1249
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Geerinckx Barbara¹²,Teuwen Laure-Anne²,Foo Tiffany¹,Vandamme Timon²,Smith Annabel¹,Peeters Marc²,Price Timothy¹³

Affiliation:

1. Department of Medical Oncology, The Queen Elizabeth Hospital, Woodville, Australia

2. Department of Oncology and Multidisciplinary Oncological Center of Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium

3. School of Medicine, University of Adelaide, Adelaide, Australia

Funder

Fund for Scientific Research (FWO) Flanders

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2023.2270161

Reference94 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

3. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

4. Gemcitabine plus nab‐paclitaxel versus FOLFIRINOX for unresected pancreatic cancer: Comparative effectiveness and evaluation of tumor growth in Veterans

5. NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different origin-derived exosomes and their clinical advantages in cancer therapy;Frontiers in Immunology;2024-06-27

2. The Role of Nrf2 in the Regulation of Mitochondrial Function and Ferroptosis in Pancreatic Cancer;Antioxidants;2024-06-06

3. Theranostics: Timing is Everything;Cancer Biotherapy and Radiopharmaceuticals;2024-05-17

4. Molecular Classification and Pathogenesis of Pancreatic Adenocarcinoma and Targeted Therapies: A Review;Frontiers in Bioscience-Landmark;2024-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3